Economic evaluations of trastuzumab in HER2-positive metastatic breast cancer: a systematic review and critique

被引：0
|
作者：
Bonny Parkinson
Sallie-Anne Pearson
Rosalie Viney
机构：
[1] University of Technology,Centre for Health Economics Research and Evaluation (CHERE)
[2] Sydney,Pharmacoepidemiology and Pharmaceutical Policy Research Group, Faculty of Pharmacy
[3] The University of Sydney,undefined
来源：
The European Journal of Health Economics | 2014年 / 15卷
关键词：
Economics; Cost-utility analysis; Cost-effectiveness analysis; Breast neoplasms; Metastatic; Trastuzumab; I18; D61;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：93 / 112
页数：19
相关论文
共 50 条
  • [41] A systematic review of trastuzumab and lapatinib in the treatment of women with brain metastases from HER2-positive breast cancer
    Larsen, Pia Bukmann
    Kumler, Iben
    Nielsen, Dorte Lisbet
    CANCER TREATMENT REVIEWS, 2013, 39 (07) : 720 - 727
  • [42] A systematic review of dual targeting in HER2-positive breast cancer
    Kumler, Iben
    Tuxen, Malgorzata K.
    Nielsen, Dorte Lisbet
    CANCER TREATMENT REVIEWS, 2014, 40 (02) : 259 - 270
  • [43] The Global Need for a Trastuzumab Biosimilar for Patients With HER2-Positive Breast Cancer
    Blackwell, Kimberly
    Gligorov, Joseph
    Jacobs, Ira
    Twelves, Chris
    CLINICAL BREAST CANCER, 2018, 18 (02) : 95 - 113
  • [44] Should trastuzumab be administered concomitantly with anthracycline in women with early, HER2-positive breast cancer?
    Montemurro, Filippo
    TRANSLATIONAL CANCER RESEARCH, 2014, 3 (06) : 541 - 546
  • [45] HER2 Heterogeneity Affects Trastuzumab Responses and Survival in Patients With HER2-Positive Metastatic Breast Cancer
    Lee, Hee Jin
    Seo, An Na
    Kim, Eun Joo
    Jang, Min Hye
    Suh, Koung Jin
    Ryu, Han Suk
    Kim, Yu Jung
    Kim, Jee Hyun
    Im, Seock-Ah
    Gong, Gyungyub
    Jung, Kyung Hae
    Park, In Ae
    Park, So Yeon
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2014, 142 (06) : 755 - 766
  • [46] Prolonged complete remission of metastatic HER2-positive breast cancer after continuous trastuzumab treatment: a case report and review of the literature
    Isabel Ihnenfeld Arciénega
    Patrick Imesch
    Daniel Fink
    Konstantin J. Dedes
    Targeted Oncology, 2015, 10 : 297 - 301
  • [47] Prolonged complete remission of metastatic HER2-positive breast cancer after continuous trastuzumab treatment: a case report and review of the literature
    Arcienega, Isabel Ihnenfeld
    Imesch, Patrick
    Fink, Daniel
    Dedes, Konstantin J.
    TARGETED ONCOLOGY, 2015, 10 (02) : 297 - 301
  • [48] Targeted therapy in HER2-positive metastatic breast cancer: a review of the literature
    Zhu, X.
    Verma, S.
    CURRENT ONCOLOGY, 2015, 22 : S19 - S28
  • [49] Management of metastatic HER2-positive breast cancer: present and future
    Guiu, S.
    Coudert, B.
    Favier, L.
    Arnould, L.
    Fumoleau, P.
    BULLETIN DU CANCER, 2010, 97 (03) : 365 - 383
  • [50] Trastuzumab and Vinorelbine in Early Stages of HER2-Positive Breast Cancer
    Ferrario, C.
    Wong, A.
    Gao, T.
    Bouganim, N.
    Aloyz, R.
    Panasci, L. C.
    JOURNAL OF CHEMOTHERAPY, 2011, 23 (01) : 32 - 35
12345